Selecting constant serum estradiol levels achieved by vaginal rings

Area of Science:

• Endocrinology
• Reproductive Biology
• Pharmacology

Background:

• Prolonged, constant systemic administration of estradiol-17 beta is valuable for research and clinical applications.
• Sustained delivery can be achieved using estradiol-17 beta-containing polydimethylsiloxane vaginal rings.
• Precise control over circulating estradiol-17 beta levels is desirable.

Purpose of the Study:

• To investigate how altering the surface area and estradiol-17 beta content of vaginal rings affects resulting serum estradiol-17 beta levels.
• To determine if estradiol-17 beta vaginal rings can replicate specific phases of the normal menstrual cycle.

Main Methods:

• Estradiol-17 beta vaginal rings with varying dosages (100 mg, 200 mg, 400 mg) were used for three months.
• Serum estradiol-17 beta levels were measured during the exposure period.
• The obtained estradiol-17 beta levels were compared to those observed during normal menstrual cycles.

Main Results:

• Average serum estradiol-17 beta levels were 53 ± 10 pg/mL (100 mg ring), 81 ± 7 pg/mL (200 mg ring), and 152 ± 14 pg/mL (400 mg ring).
• These levels corresponded to the early follicular, mid-follicular, and complete menstrual cycle phases, respectively.
• Stable circulating estradiol-17 beta levels were achieved.

Conclusions:

• Estradiol-17 beta vaginal ring administration results in stable circulating estradiol-17 beta levels.
• These levels effectively mimic the estradiol-17 beta concentrations characteristic of specific phases of the normal menstrual cycle.
• Estradiol-17 beta vaginal rings show potential utility in both research and clinical settings for hormone therapy.